SLC39A1 and prostate carcinoma: Ectopic expression of SLC39A1 suppressed nuclear factor-κB (NF-κB) in prostate cancer cells in vitro and in vivo and consequently upregulated expression of pro-angiogenic and pro-metastatic cytokines [15,21].